1. Home
  2. WT vs HAE Comparison

WT vs HAE Comparison

Compare WT & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WisdomTree Inc.

WT

WisdomTree Inc.

HOLD

Current Price

$18.77

Market Cap

2.8B

Sector

Finance

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$77.49

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WT
HAE
Founded
1985
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.8B
IPO Year
2011
1996

Fundamental Metrics

Financial Performance
Metric
WT
HAE
Price
$18.77
$77.49
Analyst Decision
Hold
Buy
Analyst Count
3
9
Target Price
$17.67
$84.13
AVG Volume (30 Days)
3.3M
781.0K
Earning Date
05-01-2026
05-07-2026
Dividend Yield
0.74%
N/A
EPS Growth
127.27
N/A
EPS
N/A
2.05
Revenue
$493,753,000.00
$910,373,000.00
Revenue This Year
$35.04
N/A
Revenue Next Year
$8.68
$5.23
P/E Ratio
N/A
$37.17
Revenue Growth
15.43
N/A
52 Week Low
$10.69
$47.32
52 Week High
$20.18
$87.32

Technical Indicators

Market Signals
Indicator
WT
HAE
Relative Strength Index (RSI) 54.49 63.44
Support Level $18.50 $72.04
Resistance Level $18.91 $80.90
Average True Range (ATR) 0.77 2.70
MACD 0.18 -0.36
Stochastic Oscillator 59.60 68.79

Price Performance

Historical Comparison
WT
HAE

About WT WisdomTree Inc.

WisdomTree Inc is a financial innovator, offering a diverse suite of Exchange-traded products (ETPs), models and solutions, private market investments and digital asset-related products. It also offers digital products and services related to tokenized real world assets and stablecoins, including tokenized mutual funds (Digital Funds), as well as its institutional platform, WisdomTree Connect, and blockchain-native digital wallet, WisdomTree Prime. The company's products are distributed across various asset management industry channels, including banks, brokerage firms, registered investment advisers, institutional investors, private wealth managers and online brokers. The majority of the company's revenue is generated from advisory fees earned from ETPs.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: